Orders grew 11% year-over-year with a record backlog, while revenue rose 3.5% organically. Advanced Imaging and Pharmaceutical Diagnostics segments delivered strong growth and margin expansion, offsetting challenges in Patient Care Solutions. Full-year guidance and medium-term targets remain intact.

Based on

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.